Articles dans des revues avec comité de lecture (59)
  1. 37. Brion, J. P., Ando, K., Heraud, C., & Leroy, K. (2010). Modulation of tau pathology in tau transgenic models. Biochemical Society transactions, 38(4), 996-1000. doi:10.1042/BST0380996
  2. 38. Leroy, K., Ando, K., Heraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J. P. (2010). Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. Journal of Alzheimer's disease, 19(2), 705-719. doi:10.3233/JAD-2010-1276
  3. 39. Huysseune, S., Kienlen-Campard, P. K., Hébert, S., Tasiaux, B., Leroy, K., Devuyst, O., Brion, J. P., De Strooper, B., & Octave, J. N. (2009). Epigenetic control of aquaporin 1 expression by the amyloid precursor protein. The FASEB journal, 23(12), 4158-4167. doi:10.1096/fj.09-140012
  4. 40. Leroy, K., De Decker, R., Suain, V., Authelet, M., Yilmaz, Z., & Brion, J. P. (2009). C9 Tau et toxicité de l’amyloïde Aß dans les modèles transgéniques APP. Revue neurologique, 165(10), 23. doi:10.1016/S0035-3787(09)72562-7
  5. 41. Killick, R., Scales, G., Leroy, K., Causevic, M., Hooper, C., Irvine, E. E., Choudhury, A. I., Drinkwater, L., Kerr, F., Al-Qassab, H., Stephenson, J., Yilmaz, Z., Giese, K. P., Brion, J. P., Withers, D. J., & Lovestone, S. (2009). Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochemical and biophysical research communications, 386(1), 257-262. doi:10.1016/j.bbrc.2009.06.032
  6. 42. Boom, A., Authelet, M., Dedecker, R., Frédérick, C., Van Heurck, R., Daubie, V., Leroy, K., Pochet, R., & Brion, J. P. (2009). Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells. Biochimica et biophysica acta, 1793(6), 1058-1067. doi:10.1016/j.bbamcr.2008.11.011
  7. 43. Langer, I., Leroy, K., Gaspard, N., Brion, J. P., & Robberecht, P. (2008). Cell surface targeting of VPAC1 receptors: evidence for implication of a quality control system and the proteasome. Biochimica et biophysica acta, 1783(9), 1663-1672. doi:10.1016/j.bbamcr.2008.03.013
  8. 44. Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J. P. (2007). Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. The American journal of pathology, 171(3), 976-992. doi:10.2353/ajpath.2007.070345
  9. 45. Leroy, K., Yilmaz, Z., & Brion, J. P. (2007). Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathology and applied neurobiology, 33(1), 43-55. doi:10.1111/j.1365-2990.2006.00795.x
  10. 46. Schindowski, K., Bretteville, A., Leroy, K., Bégard, S., Brion, J. P., Hamdane, M., & Buée, L. (2006). Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. The American journal of pathology, 169(2), 599-616. doi:10.2353/ajpath.2006.060002
  11. 47. Feyt, C., Kienlen-Campard, P. K., Leroy, K., N'Kuli, F., Courtoy, P., Brion, J. P., & Octave, J. N. (2005). Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3. The Journal of biological chemistry, 280(39), 33220-33227. doi:10.1074/jbc.M501610200
  12. 48. Derkinderen, P., Scales, T. M. E., Hanger, D., Leung, K.-Y., Byers, H. L., Ward, M. A., Lenz, C., Price, C., Bird, I. N., Perera, T., Kellie, S., Williamson, R., Noble, W., Van Etten, R. A., Leroy, K., Brion, J. P., Reynolds, C. H., & Anderton, B. (2005). Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. The Journal of neuroscience, 25(28), 6584-6593. doi:10.1523/JNEUROSCI.1487-05.2005
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 Suivant >>